NEW YORK, April 4 - Protein Pathways said this week that it has started a research collaboration with Merck.
Wyeth will apply the company's pathway prediction technology to its drug discovery efforts.
Protein Pathways, based in
It has constructed a human protein interaction map that includes more than 200,000 predicted interactions.
The company exclusively licenses technology developed by David Eisenberg at the